Cargando…
COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study
The aim of this study was to describe the outcomes of patients with coronavirus disease 2019 (COVID-19) in the outpatient setting after early treatment with zinc, low-dose hydroxychloroquine and azithromycin (triple therapy) dependent on risk stratification. This was a retrospective case series stud...
Autores principales: | Derwand, Roland, Scholz, Martin, Zelenko, Vladimir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587171/ https://www.ncbi.nlm.nih.gov/pubmed/33122096 http://dx.doi.org/10.1016/j.ijantimicag.2020.106214 |
Ejemplares similares
-
Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?
por: Derwand, R., et al.
Publicado: (2020) -
QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020) -
Assessment of Recovery Time, Worsening, and Death among Inpatients and Outpatients with COVID-19, Treated with Hydroxychloroquine or Chloroquine plus Azithromycin Combination in Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2022) -
Hydroxychloroquine- and azithromycin-related heart disorders
Publicado: (2020) -
Hydroxychloroquine + azithromycin treatment in elderly patients
por: Gautret, Philippe, et al.
Publicado: (2021)